Lv4
520 积分 2023-09-15 加入
PPAR-γ signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets
6天前
已完结
Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)
6天前
已完结
Mitigation of non-alcoholic steatohepatitis via recombinant Orosomucoid 2, an acute phase protein modulating the Erk1/2-PPARγ-Cd36 pathway
6天前
已完结
CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis
19天前
已完结
CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis
24天前
已完结
Isoflavones as a smart curer for non-alcoholic fatty liver disease and pathological adiposity via ChREBP and Wnt signaling
2个月前
已完结
Wnt5b stimulates adipogenesis by activating PPARγ, and inhibiting the β-catenin dependent Wnt signaling pathway together with Wnt5a
2个月前
已关闭
Current Progress and Challenges in the Development of Pharmacotherapy for Metabolic Dysfunction‐Associated Steatohepatitis
2个月前
已完结
Mechanism and regulation of mitophagy in nonalcoholic fatty liver disease (NAFLD): A mini-review
2个月前
已完结
Glycyrrhizin accelerates the metabolism of triptolide through induction of CYP3A in rats
2个月前
已完结
皖公网安备34019202002308
